Ligand Pharmaceuticals Inc. Provides New Corporate Presentation at Investor Conference

Published: May 29, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) management provided a new corporate presentation today at the Deutsche Bank 38th Annual dbAccess Health Care Conference in Boston. The presentation highlighted Ligand's expanding portfolio of pharmaceutical royalty assets, demonstrated how the company may be approaching an inflection point for acceleration in earnings growth, provided an outlook for 11 potential program launches through 2017 and illustrated potential royalty cash-flows through 2020 based on third-party forecasts on the Company’s current royalty assets.

Help employers find you! Check out all the jobs and post your resume.

Back to news